Post navigation 13 der 20 führenden Biopharmaunternehmen setzen weltweit auf Veeva Link Key PeopleEvogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer